DATA
DEAD

Serial Number

79357621

Owner

1MED SA

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DATA Trademark

Serial Number: 79357621

DATA is a trademark filed by 1MED SA on September 14, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

1MED SA (4 trademarks)

Via Campagna 13

Entity Type: 99

Trademark Details

Filing Date

September 14, 2022

Registration Date

Not Registered

Goods & Services

Software; software and applications for mobile devices; downloadable software applications; specialized software; collaborative software; data communication software; file sharing software; document management software; software for management of data and files and for databases; process control software; data processing software; product lifecycle management software; industrial process management software; software for production process monitoring, analysis, control and operation; software for verification of the regulatory compliance of goods; software for monitoring the regulatory compliance of clinical trials; software for quality control in the field of medical devices and the pharmaceutical industry; software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials

Providing access to and rental of access time to a database; providing access to data or documents in electronic format on centralized files for remote consultation; providing access to platforms and portals on the Internet; electronic transmission of messages, data and documents

Hosting services and software as a service and rental of software; development, programming and implementation of software; development, programming and implementation of data processing software; development, programming and implementation of software for checking the regulatory compliance of goods; development, programming and implementation of software for quality control of goods and clinical studies; accreditation services (certification of skills and quality) in the field of medical devices and the pharmaceutical industry; certification (quality control); quality control consultation; analysis and assessment of product design in the field of medical devices and the pharmaceutical industry; qualitative assessment of the performance of pharmaceuticals, medical products and medical devices; providing information on product development; preliminary assessment services in the field of new pharmaceuticals, medical products and medical devices; pharmaceutical research and development consultation services; consultation services on product development in the field of medical devices and the pharmaceutical industry; providing information on the results of clinical trials for pharmaceuticals, medical products and medical devices; design and development of medical technologies; design and development of analytical methods and tests; research and development services in the field of medical devices and pharmaceuticals; scientific and technological design services; conducting of scientific feasibility studies; carrying out technical feasibility studies; feasibility studies with respect to product design; feasibility studies with respect to analysis of materials; feasibility studies with respect to clinical trials; planning and conducting preclinical and clinical studies; providing medical and scientific research information of pharmaceuticals and clinical trials; conducting clinical trials for third parties (scientific research); conducting clinical trials for pharmaceuticals, medical products and medical apparatus; conducting of clinical studies; scientific research; medical research; pharmaceutical research and development; study of technical projects in the field of medical devices and the pharmaceutical industry; assessment of chemical information in relation to risks; assessment of toxicological information in relation to risks; risk assessment in the field of medical devices and the pharmaceutical industry; scientific assessment of risks; analytical laboratory services; laboratory research services relating to pharmaceuticals, medical devices and medical products; scientific laboratory services; advisory services with respect to laboratory tests; scientific diagnostic test services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 3, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 15, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Feb 21, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 11, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 15, 2024 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 20, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 20, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 20, 2024 ABN2
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 7, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 1, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 1, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 30, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 16, 2022 REPR